ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Halley E Gilbert sold $455K of Arcutis Biotherapeutics, Inc.
Sold$455,442
$27.55Price
16,532Shares
−43%Stake
What ARQT did after the filing
- The stock from Fri, Nov 21 close, $29.49
- +0.3%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Jan 7 close.
Traded Thu, Nov 20. Filed Fri, Nov 21, 1:21 PM ET, during the session. Returns use the Nov 21 close and the Jan 7 close. Not investment advice.